[
    [
        {
            "time": "",
            "original_text": "机构看好黄金、光伏板块，资金加仓这些股（名单）",
            "features": {
                "keywords": [
                    "黄金",
                    "光伏",
                    "资金加仓"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "黄金",
                    "光伏"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "机构看好黄金、光伏板块，资金加仓这些股（名单）",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-12-09",
            "original_text": "【山证医药】医药行业周报（20181209）：带量采购超预期，仿制药行业将变天",
            "features": {
                "keywords": [
                    "医药",
                    "带量采购",
                    "仿制药",
                    "超预期"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【山证医药】医药行业周报（20181209）：带量采购超预期，仿制药行业将变天",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-12-09",
            "original_text": "首次带量采购落地，继续重点看好特色原料药、制剂出口、创新药等领域的投资机会【周观点|长江医药1209】",
            "features": {
                "keywords": [
                    "带量采购",
                    "特色原料药",
                    "制剂出口",
                    "创新药",
                    "投资机会"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "原料药",
                    "制剂出口",
                    "创新药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "首次带量采购落地，继续重点看好特色原料药、制剂出口、创新药等领域的投资机会【周观点|长江医药1209】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "带量采购引发医药股“雪崩” 2019年行业板块将如何演绎",
            "features": {
                "keywords": [
                    "带量采购",
                    "医药股",
                    "雪崩"
                ],
                "sentiment_score": -0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "带量采购引发医药股“雪崩” 2019年行业板块将如何演绎",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业2019年度策：坚守创新企业迎产业变局",
            "features": {
                "keywords": [
                    "医药生物",
                    "创新",
                    "产业变局"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物",
                    "创新"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2019年度策：坚守创新企业迎产业变局",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医药板块的“至暗时刻”！“4+7”带量采购降价幅度远超市场预期！恒瑞医药蒸发百亿",
            "features": {
                "keywords": [
                    "医药板块",
                    "4+7",
                    "带量采购",
                    "降价",
                    "恒瑞医药"
                ],
                "sentiment_score": -0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药板块的“至暗时刻”！“4+7”带量采购降价幅度远超市场预期！恒瑞医药蒸发百亿",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 10,
                "Entity_Density": 9,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 5
            }
        }
    ]
]